These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 31824672)
1. Delayed administration of recombinant plasma gelsolin improves survival in a murine model of severe influenza. Yang Z; Bedugnis A; Levinson S; DiNubile M; Stossel T; Lu Q; Kobzik L F1000Res; 2019; 8():1860. PubMed ID: 31824672 [No Abstract] [Full Text] [Related]
2. Delayed Administration of Recombinant Plasma Gelsolin Improves Survival in a Murine Model of Penicillin-Susceptible and Penicillin-Resistant Pneumococcal Pneumonia. Yang Z; Bedugnis A; Levinson S; Dinubile M; Stossel T; Lu Q; Kobzik L J Infect Dis; 2019 Sep; 220(9):1498-1502. PubMed ID: 31287867 [TBL] [Abstract][Full Text] [Related]
3. Recombinant Human Plasma Gelsolin Improves Survival and Attenuates Lung Injury in a Murine Model of Multidrug-Resistant DiNubile MJ; Levinson SL; Stossel TP; Lawrenz MB; Warawa JM Open Forum Infect Dis; 2020 Aug; 7(8):ofaa236. PubMed ID: 32766380 [TBL] [Abstract][Full Text] [Related]
4. Plasma gelsolin improves lung host defense against pneumonia by enhancing macrophage NOS3 function. Yang Z; Chiou TT; Stossel TP; Kobzik L Am J Physiol Lung Cell Mol Physiol; 2015 Jul; 309(1):L11-6. PubMed ID: 25957291 [TBL] [Abstract][Full Text] [Related]
5. Safety and Pharmacokinetics of Recombinant Human Plasma Gelsolin in Patients Hospitalized for Nonsevere Community-Acquired Pneumonia. Tannous A; Levinson SL; Bolognese J; Opal SM; DiNubile MJ Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32690640 [TBL] [Abstract][Full Text] [Related]
6. Adjunctive Recombinant Human Plasma Gelsolin for Severe Coronavirus Disease 2019 Pneumonia. DiNubile MJ; Parra S; Salomó AC; Levinson SL Open Forum Infect Dis; 2022 Aug; 9(8):ofac357. PubMed ID: 35928505 [TBL] [Abstract][Full Text] [Related]
7. Recombinant human plasma gelsolin (rhu-pGSN) in a patient hospitalized with critical COVID-19 pneumonia. Catteeuw JV; DiNubile MJ Clin Infect Pract; 2021 Nov; 12():100088. PubMed ID: 34396087 [TBL] [Abstract][Full Text] [Related]
8. Plasma gelsolin modulates the production and fate of IL-1β-containing microparticles following high-pressure exposure and decompression. Bhopale VM; Ruhela D; Brett KD; Nugent NZ; Fraser NK; Levinson SL; DiNubile MJ; Thom SR J Appl Physiol (1985); 2021 May; 130(5):1604-1613. PubMed ID: 33764168 [TBL] [Abstract][Full Text] [Related]
9. Recombinant Human Plasma Gelsolin Stimulates Phagocytosis while Diminishing Excessive Inflammatory Responses in Mice with Piktel E; Wnorowska U; Cieśluk M; Deptuła P; Prasad SV; Król G; Durnaś B; Namiot A; Markiewicz KH; Niemirowicz-Laskowska K; Wilczewska AZ; Janmey PA; Reszeć J; Bucki R Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32272559 [TBL] [Abstract][Full Text] [Related]
10. Low Admission Plasma Gelsolin Concentrations Identify Community-acquired Pneumonia Patients at High Risk for Severe Outcomes. Self WH; Wunderink RG; DiNubile MJ; Stossel TP; Levinson SL; Williams DJ; Anderson EJ; Bramley AM; Jain S; Edwards KM; Grijalva CG Clin Infect Dis; 2019 Sep; 69(7):1218-1225. PubMed ID: 30561561 [TBL] [Abstract][Full Text] [Related]
11. Plasma gelsolin and circulating actin correlate with hemodialysis mortality. Lee PS; Sampath K; Karumanchi SA; Tamez H; Bhan I; Isakova T; Gutierrez OM; Wolf M; Chang Y; Stossel TP; Thadhani R J Am Soc Nephrol; 2009 May; 20(5):1140-8. PubMed ID: 19389844 [TBL] [Abstract][Full Text] [Related]
13. Modifications of cellular responses to lysophosphatidic acid and platelet-activating factor by plasma gelsolin. Osborn TM; Dahlgren C; Hartwig JH; Stossel TP Am J Physiol Cell Physiol; 2007 Apr; 292(4):C1323-30. PubMed ID: 17135294 [TBL] [Abstract][Full Text] [Related]
14. Persistent depletion of plasma gelsolin (pGSN) after exposure of mice to heavy silicon ions. Rithidech KN; Reungpatthanaphong P; Tungjai M; Jangiam W; Honikel L; Whorton EB Life Sci Space Res (Amst); 2018 May; 17():83-90. PubMed ID: 29753417 [TBL] [Abstract][Full Text] [Related]
15. Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolin. Gerber E; Asare-Werehene M; Reunov A; Burger D; Le T; Carmona E; Mes-Masson AM; Tsang BK J Ovarian Res; 2023 Jan; 16(1):14. PubMed ID: 36642715 [TBL] [Abstract][Full Text] [Related]
16. The effects of plasma gelsolin on human erythroblast maturation for erythrocyte production. Han SY; Lee EM; Choi HS; Chun BH; Baek EJ Stem Cell Res; 2018 May; 29():64-75. PubMed ID: 29597129 [TBL] [Abstract][Full Text] [Related]
17. Plasma Gelsolin and Its Association with Mortality and Hospitalization in Chronic Hemodialysis Patients. Flores Gama C; Rosales LM; Ouellet G; Dou Y; Thijssen S; Usvyat L; Zhang H; Kuntsevich V; Levin NW; Kotanko P Blood Purif; 2017; 43(1-3):210-217. PubMed ID: 28114138 [TBL] [Abstract][Full Text] [Related]
18. Gelsolin decreases actin toxicity and inflammation in murine multiple sclerosis. Li-ChunHsieh K; Schob S; Zeller MW; Pulli B; Ali M; Wang C; Chiou TT; Tsang YM; Lee PS; Stossel TP; Chen JW J Neuroimmunol; 2015 Oct; 287():36-42. PubMed ID: 26439960 [TBL] [Abstract][Full Text] [Related]
19. Plasma gelsolin depletion and circulating actin in sepsis: a pilot study. Lee PS; Patel SR; Christiani DC; Bajwa E; Stossel TP; Waxman AB PLoS One; 2008; 3(11):e3712. PubMed ID: 19002257 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of plasma gelsolin administration in a rat model of sepsis. Cohen TS; Bucki R; Byfield FJ; Ciccarelli NJ; Rosenberg B; DiNubile MJ; Janmey PA; Margulies SS Cytokine; 2011 Jun; 54(3):235-8. PubMed ID: 21420877 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]